Shore Capital analyst Vivek Raja said in a note that CAB Payments’ latest regulatory milestone in the Middle East adds to the company’s global footprint and strengthens its long-term growth outlook. 

Hemogenyx Pharmaceuticals (LSE: HEMO) shares jumped more than 11% on Wednesday after the company announced a milestone in the development of its HG-CT-1 CAR-T therapy. The

Journeo plc (LON: JNEO), a provider of intelligent transport systems, has announced a significant contract win, securing purchase orders worth US$5.0 million to supply platform display systems for the Metropolitan Transportat

GSK (LON: GSK) delivered a robust third-quarter performance, prompting an upgrade to its full-year 2025 guidance and sending its shares over 3% higher at the open on Wednesday.

Next PLC (LON: NXT) significantly outperformed expectations in its third-quarter trading statement, leading to increased full-year profit guidance. The retailer's full-pri

Aston Martin (LON: AML) reported a challenging third quarter, reflecting previously disclosed lower wholesale volumes and macroeconomic pressures. Despite the current down

Elementis PLC (LON: ELM), a global specialty chemicals company, released its third-quarter trading update, showcasing a resilient performance amidst ongoing market challenges.

genedrive plc (LSE: GDR) witnessed a significant jump in its share price following the announcement of a Memorandum of Understanding (MOU) with the Kingdom of Saudi Arabia (KSA) Ministry of Health (MOH).

Jefferies has initiated coverage of two of Britain’s largest pharmaceutical companies, GSK and AstraZeneca, with Buy ratings, citing strong pipelines and potential for long-term growth across their core businesses.

REACT Group Plc (AIM: REAT), a specialist support services provider, has announced a robust trading update for the year ended September 30, 2025 (FY25). The company's perf

evoke Plc (LSE: EVOK), a global betting and gaming leader, announced a 5% increase in revenue for Q3 2025, reaching £435 million. This marks the fifth consecutive quarter of year-over-year revenue growth, driven by positive p

GSK plc (LON: GSK) announced its B7-H3-targeted antibody-drug conjugate (ADC), GSK'227, has been granted Orphan Drug Designation (ODD) by the European Medicines Agency (EMA) for pulmonary neuroendocrine carcinoma (NEC), a cat

RWS Holdings plc (LON: RWS), a content solutions provider, has released a year-end trading statement, projecting full-year adjusted PBT within its previously issued guidance range.

HSBC Holdings plc (LON: HSBA) released its 3Q25 earnings on Tuesday, revealing a decline in reported profit before tax, although the bank upgraded its full-year RoTE target.

Dowlais Group PLC (LON: DWL) and American Axle & Manufacturing Holdings, Inc. (NYSE: AXL) have announced a significant step forward in their proposed combination, securing unconditional clearance from the European Commiss

Grainger PLC (LON: GRI), the UK's largest listed provider of private rental homes, is strategically positioned to benefit from the Renters' Rights Bill, recently passed by the House of Commons.

Goodwin PLC (LON: GDWN) has seen its share price jump more than 16% early on Monday after it significantly raised its profit expectations for the financial year ending April 30, 2026, and declared a special interim dividend.

Kromek Group plc (LON: KMK) has announced that it expects a substantial increase in revenue for the first half of fiscal year 2026, signaling a period of strong growth for the global detection technology company.

Greencore Group PLC (LON: GNC) and Bakkavor Group plc received positive news from the UK's Competition and Markets Authority (CMA) regarding Greencore's proposed acquisition of Bakkavor.

RTW Biotech Opportunities Ltd (LON: RTW) is set to benefit from Novartis's acquisition of Avidity Biosciences, Inc. (Nasdaq: RNA), one of its portfolio companies. The deal

Avacta Therapeutics (AIM: AVCT) has revealed encouraging preclinical data for its dual payload pre|CISION medicines at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.

Strategic Minerals plc (LON: SML) reported a robust 31.9% increase in revenue for Q3 2025, driven by a strong rebound in ore sales at its Cobre magnetite operation in New Mexico, USA.

EQTEC plc (AIM:EQT), a waste-to-energy technology firm, announced significant leadership changes and a new funding facility, signalling a strategic reset aimed at improving capital efficiency and operational execution.